Join us for an educational discussion on histotripsy, an emerging treatment for liver tumors.
A multi-disciplinary team of experts from Dana-Farber Cancer Institute and Brigham and Women’s Hospital will explain how histotripsy works, who may benefit, and what patients should consider when evaluating this and other treatment options for hepatic EHE.
This session, led by Dr. Jiping Wang, Surgical Oncologist, Dr. Paul Shyn, Department of Radiology, and Dr. Michael Wagner, Medical Oncologist, is intended to help people with EHE tumors in the liver, with or without metastatic disease, gain knowledge that supports informed care decisions.